PPD Accelerates Clinical Trial Data Collection and Reporting With Oracle(R) Remote Data Capture 4.5.3

Oracle and PPD Build on Long-Standing Relationship to Deliver Faster, Easier-to-Use Application at Clinical Trial Investigative Sites

BOSTON, June 24 /PRNewswire-FirstCall/ -- DIA 44th Annual meeting --

-- Today, Oracle and PPD, Inc. (Nasdaq: PPDI - News), a leading global contract research organization (CRO), announced that PPD has implemented Oracle® Remote Data Capture (RDC) Onsite 4.5.3, the newest version of Oracle's electronic data capture (EDC) solution, across eight active studies and 600 global investigative sites.

-- PPD integrated Oracle RDC Onsite 4.5.3 into its suite of clinical trial management applications this past March to accelerate entry and management of clinical trial data and to expand real-time reporting capabilities for its pharmaceutical, biotechnology and medical device clients.

-- Oracle RDC Onsite 4.5.3 has proven easier and faster to use with electronic case report form (eCRF) pages opening in two to three seconds. In addition, Oracle RDC Onsite 4.5.3 requires fewer key strokes to navigate pages, displays all information on a single CRF screen and allows investigators to open multiple pages simultaneously.

-- Users can also leverage the system's integrated discrepancy management capabilities to accelerate data corrections across the system.

-- PPD is leveraging the enhanced product's zero footprint to streamline system and site set-up and management. Oracle RDC Onsite 4.5.3, which is accessed via a Web browser and standard Internet connection, does not require investigational sites to load or maintain additional software, reducing information technology management complexity. The system also includes 128-bit encryption to keep data secure.

-- PPD, as part of a group of customer advisors, worked closely with Oracle to develop new functionality for Oracle RDC Onsite 4.5.3, focusing particularly on increasing investigator site performance, simplifying the user interface and eliminating site software installation through a fully Web-based EDC system.

-- PPD has integrated its interactive voice response (IVR) system with the Oracle Clinical platform. Investigators can now enroll and/or randomize patients with the IVR, automatically transmitting enrollment data into the Oracle Clinical and Oracle Remote Data Capture Onsite system, all during the same phone call.

-- Oracle RDC Onsite 4.5.3 helps life sciences organizations and CROs conduct clinical trials and studies more effectively and efficiently. Fully integrated with Oracle Clinical, Oracle Remote Data Capture Onsite 4.5.3 features an enhanced user interface and expanded reporting capabilities.

-- PPD has worked with Oracle since 2000 to develop Oracle Clinical solutions.

Supporting Quote

-- "Extensive collaboration between Oracle and PPD has resulted in a greatly enhanced version of Oracle Remote Data Capture Onsite that focuses on ease of use for trial investigators and improved manageability of the system," said Susan Atkinson, senior vice president of global biostatistics and data management at PPD. "We, along with our industry colleagues, worked with Oracle throughout the development process, which included extensive field testing. Our project managers and site investigators have reported a marked improvement in usability and navigation speed with Oracle Remote Data Capture 4.5.3, which is resulting in faster, more accurate data entry, thus accelerating the clinical trial process for our clients."

About PPD

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 31 countries and more than 10,400 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at http://www.ppdi.com.

About Oracle

Oracle (Nasdaq: ORCL - News) is the world's largest enterprise software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.

Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about PPD's relationship with Oracle and the performance and value of this technology, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: rapid technological advances that make our products and services less competitive; risks associated with and dependence on collaborative relationships; competition within the outsourcing industry; continued success in sales growth; loss of large contracts; increased cancellation rates; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; the ability to attract and retain key personnel; risks associated with the development and commercialization of drugs, including earnings dilution and obtaining regulatory approval; risks associated with acquisitions and investments, such as impairments; risks that we may not continue our dividend policy; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.

Trademarks

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

Printer Friendly

Email Page

Sponsor Message